MSB 10.8% $1.38 mesoblast limited

"More evidence suggests no long-term COVID-19 immunity"So the...

  1. 327 Posts.
    lightbulb Created with Sketch. 1340
    "More evidence suggests no long-term COVID-19 immunity"

    So the magic bullet is not going to be vaccine. At least part of the solution would lie in therapeutics, like Remestemcel-L produced by Mesoblast.

    https://hotcopper.com.au/data/attachments/2297/2297517-e410456111a8ad66bbc7ff6d7e0c73a6.jpg
    https://hotcopper.com.au/data/attachments/2297/2297519-f3fa32545697416ca1adfc243430a634.jpg
    https://hotcopper.com.au/data/attachments/2297/2297522-e621b6859c0cfa9d739df03ddb007a91.jpg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.